However, only 20% of ovarian cancer cases can be detected at stage I or II [International Federation of Gynecology and Obstetrics (FIGO)] by conventional gynecologic examination combined with the measurement of carbohydrate antigen 125 (CA125) in serum and transvaginal ultrasound. Here, MUC16 is linked to ovarian carcinoma.